You are here

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
Aichi Medical University Hospital
Nagakute, Aichi, 480-1195 Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Deep Vein Thrombosis, Pulmonary Embolism
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
20 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Acute symptomatic proximal DVT with evidence of proximal thrombosis

- Acute symptomatic PE with evidence of thrombosis in segmental or more proximal
branches

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Active bleeding or high risk for bleeding contraindicating treatment with UFH and a
VKA.

- Uncontrolled hypertension: systolic blood pressure > 180 mm Hg or diastolic blood
pressure > 110 mm Hg

- Subjects requiring dual anti-platelet therapy

NCT01780987
Pfizer
Completed
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Thromboembolism, Deep Vein Thrombosis, Dalteparin
NCT00655122
All Genders
65+
Years
Multiple Sites
Venous Thrombosis, Pulmonary Embolism, Intracranial Sinus Thrombosis
NCT01297348
Females
Deep Vein Thrombosis, Pulmonary Embolism
NCT01780987
All Genders
20+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now